An HIV-derived nucleoside therapy now treats rare genetic diseases by restoring mitochondrial DNA and improving muscle ...

Despite highly effective HIV prevention drugs on the market, only a fraction of those at risk in the U.S. are taking them — or even know they're an option. It's called pre-exposure prophylaxis, or ...

The 1980s painted a bleak picture for those diagnosed with HIV/AIDS. It was a death sentence shrouded in fear and uncertainty. Yet, during that bleak era, a beacon of hope ignited: antiretroviral ...

Lynn Norment, a columnist for The Commercial Appeal, is a former editor for Ebony Magazine. It’s not shocking or even surprising that HIV and AIDS are on the rise in today’s world. The dreaded disease ...

In recent years, the story around HIV has shifted dramatically. What was once viewed as a life sentence is now increasingly seen as a manageable condition. Medication is responsible for much of that ...

After nearly a decade of working as an advocate for HIV and AIDS treatment, Michael Chancley said he came to a sobering realization. “Seeing that people who look like me, who hang out at the same ...

Sara Moniuszko is a health and lifestyle reporter at CBSNews.com. Previously, she wrote for USA Today, where she was selected to help launch the newspaper's wellness vertical. She now covers breaking ...

A Q&A With Shauna Applin, ARNP. AJMC: Despite substantial therapeutic advances since the 1980s, the US is not on pace to achieve the goals of the Ending the HIV Epidemic (EHE) public health initiative ...

A common medication used to manage and treat HIV is becoming increasingly resistant, according to a report from the World Health Organization. Dolutegravir is an antiretroviral medication that is ...

A mix of domestic revenue generation, efficiency gains and strategic partnerships is essential to sustain and expand HIV ...